Katie Upham
Biographic Data
| ID | 8982674 |
|---|---|
| NAME | Katie Upham |
| GIVEN NAMES | Katie |
| FAMILY NAME | Upham |
| SIGNATURE | UPHAM K |
| AFFILIATIONS | Centre for Addiction and Mental Health Toronto Ontario Canada |
| ORCID | 0009-0005-9051-2994 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
“A sense of community.” A qualitative descriptive study on how to build relationships and rapport with people with lived/living experience and caregivers engaged in mental health and substance use hea…
Engaging people with lived/living experience (PLLEX) and caregivers (-C) is becoming more widely adopted in mental health and substance use health research. Their engagement meaningfully improves the relevance and impact of research outcomes. Yet, authentic engagement can be difficult to achieve without building and maintaining strong relationships with PLLEX-C. This qualitative descriptive study explores the perspectives of PLLEX-C engaged in me…
Writing Patient Engagement Effectively Into Grant Applications
Engaging people with lived/living experience and caregivers in research (also known as ‘patient engagement’ or ‘patient and public involvement’) has many benefits to research, to the community, and to the people involved in the process [1]. Engagement is increasingly valued by many funding bodies [2, 3] as being best practice when possible. However, funding barriers have been described as getting in the way of authentic engagement [4]. It is ther…
The impact of the Covid-19 pandemic on access to harm reduction and treatment services among people who inject drugs in Toronto, Canada
(230 words) The COVID-19 pandemic and related restrictions exacerbated Canada’s ongoing drug toxicity overdose crisis. Opioid agonist therapy (OAT), safer opioid supply (SOS), and supervised consumption sites (SCS) are interventions that aim to reduce risk of morbidity and mortality from drug toxicity and were affected by COVID-19. Between September and October 2020, we conducted qualitative interviews with 24 people who inject drugs receiving se…
Gaps in the Engagement of People With Lived and Living Experience and Caregivers in Mental Health and Substance Use Health Research
BACKGROUND: People with lived/living experience and family/caregivers (PLLEX-C) can be engaged in mental health and substance use health research in roles such as advisors, collaborators, and co-researchers. While there is a substantial body of research describing the barriers and facilitators to effective lived experience engagement, the actual contributions that PLLEX-C are making to the research remains under-explored. This qualitative descrip…
No prominent works on this page.
The impact of the Covid-19 pandemic on access to harm reduction and treatment services among people who inject drugs in Toronto, Canada
(230 words) The COVID-19 pandemic and related restrictions exacerbated Canada’s ongoing drug toxicity overdose crisis. Opioid agonist therapy (OAT), safer opioid supply (SOS), and supervised consumption sites (SCS) are interventions that aim to reduce risk of morbidity and mortality from drug toxicity and were affected by COVID-19. Between September and October 2020, we conducted qualitative interviews with 24 people who inject drugs receiving se…
Gaps in the Engagement of People With Lived and Living Experience and Caregivers in Mental Health and Substance Use Health Research
BACKGROUND: People with lived/living experience and family/caregivers (PLLEX-C) can be engaged in mental health and substance use health research in roles such as advisors, collaborators, and co-researchers. While there is a substantial body of research describing the barriers and facilitators to effective lived experience engagement, the actual contributions that PLLEX-C are making to the research remains under-explored. This qualitative descrip…
“A sense of community.” A qualitative descriptive study on how to build relationships and rapport with people with lived/living experience and caregivers engaged in mental health and substance use hea…
Engaging people with lived/living experience (PLLEX) and caregivers (-C) is becoming more widely adopted in mental health and substance use health research. Their engagement meaningfully improves the relevance and impact of research outcomes. Yet, authentic engagement can be difficult to achieve without building and maintaining strong relationships with PLLEX-C. This qualitative descriptive study explores the perspectives of PLLEX-C engaged in me…
Writing Patient Engagement Effectively Into Grant Applications
Engaging people with lived/living experience and caregivers in research (also known as ‘patient engagement’ or ‘patient and public involvement’) has many benefits to research, to the community, and to the people involved in the process [1]. Engagement is increasingly valued by many funding bodies [2, 3] as being best practice when possible. However, funding barriers have been described as getting in the way of authentic engagement [4]. It is ther…
Mental Health and Patient Involvement (3 works) · Family Caregiving in Mental Illness (2 works) · Medicine (2 works) · Mental health (2 works) · Psychology (2 works) · Qualitative research (2 works) · Substance use (2 works) · 2019-20 coronavirus outbreak (1 work) · Best practice (1 work) · Community engagement (1 work)